| Cancers, Vol. 13, Pages 506: Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer | Cancers | 267 days | save |  |  |  |
| Cancers, Vol. 13, Pages 505: Immunohistochemical Markers in Endometrial Cancer | Cancers | 267 days | save | | | |
| Cancers, Vol. 13, Pages 504: DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment | Cancers | 267 days | save | | | |
| Cancers, Vol. 13, Pages 503: Theranostic Design of Angiopep-2 Conjugated Hyaluronic Acid Nanoparticles (Thera-ANG-cHANPs) for Dual Targeting and Boosted Imaging of Glioma Cells | Cancers | 267 days | save | | | |
| Cancers, Vol. 13, Pages 502: Predictive Factors for Pancreatic Cancer and Its Early Detection Using Special Pancreatic Ultrasonography in High-Risk Individuals | Cancers | 267 days | save | | | |
| Cancers, Vol. 13, Pages 501: Toxicity Reduction after Craniospinal Irradiation via Helical Tomotherapy in Patients with Medulloblastoma: A Unicentric Retrospective Analysis | Cancers | 267 days | save | | | |
| Cancers, Vol. 13, Pages 500: Comparative Evaluation of Novel 177Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting | Cancers | 267 days | save | | | |
| Cancers, Vol. 13, Pages 498: Desmoplastic Small Round Cell Tumor: A Review of Main Molecular Abnormalities and Emerging Therapy | Cancers | 267 days | save | | | |
| Cancers, Vol. 13, Pages 499: Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter | Cancers | 267 days | save | | | |
| Cancers, Vol. 13, Pages 497: Rectal Dose Is the Other Dosimetric Factor in Addition to Small Bowel for Prediction of Acute Diarrhea during Postoperative Whole-Pelvic Intensity-Modulated Radiotherapy in Gynecologic Patients | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 496: CD123 Is Consistently Expressed on NPM1-Mutated AML Cells | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 495: Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 494: The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 493: GYNOCARE Update: Modern Strategies to Improve Diagnosis and Treatment of Rare Gynecologic Tumors—Current Challenges and Future Directions | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 492: ID1 and ID4 Are Biomarkers of Tumor Aggressiveness and Poor Outcome in Immunophenotypes of Breast Cancer | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 491: Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 490: Mutational Signatures Driven by Epigenetic Determinants Enable the Stratification of Patients with Gastric Cancer for Therapeutic Intervention | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 489: Restoring the DREAM Complex Inhibits the Proliferation of High-Risk HPV Positive Human Cells | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 488: Effects of 1-Year Hospital Volume on Surgical Margin and Biochemical-Failure-Free Survival in Patients Undergoing Robotic Versus Nonrobotic Radical Prostatectomy: A Nationwide Cohort Study from the National Taiwan Cancer | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 485: Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 484: Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 487: DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model | Cancers | 268 days | save | | | |
| Cancers, Vol. 13, Pages 486: Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 481: Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 483: TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 482: Polycythemia Vera and Essential Thrombocythemia Patients Exhibit Unique Serum Metabolic Profiles Compared to Healthy Individuals and Secondary Thrombocytosis Patients | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 480: Integrinα3β1 Promotes Invasive and Metastatic Properties of Breast Cancer Cells through Induction of the Brn-2 Transcription Factor | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 479: The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 478: Correction: Ahn, J.W., et al. CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas. Cancers 2020, 12, 2543 | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 477: Therapeutic Strategies for Targeting IL-1 in Cancer | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 476: RUNX3 Transcript Variants Have Distinct Roles in Ovarian Carcinoma and Differently Influence Platinum Sensitivity and Angiogenesis | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 475: No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 474: Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 473: The Interplay of Exosomes and NK Cells in Cancer Biology | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 472: Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 471: Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 468: Ovulatory Follicular Fluid Facilitates the Full Transformation Process for the Development of High-Grade Serous Carcinoma | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 470: Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses and Disease Course in Patients with Papillary Thyroid Carcinoma | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 465: Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 469: The CXCL12 Crossroads in Cancer Stem Cells and Their Niche | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 467: Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 466: Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 464: Hepatic and Extrahepatic Colorectal Metastases Have Discordant Responses to Systemic Therapy. Pathology Data from Patients Undergoing Simultaneous Resection of Multiple Tumor Sites | Cancers | 269 days | save | | | |
| Cancers, Vol. 13, Pages 463: Cutaneous Findings in Neurofibromatosis Type 1 | Cancers | 270 days | save | | | |
| Cancers, Vol. 13, Pages 461: Hydrogen-Peroxide Synthesis and LDL-Uptake Controls Immunosuppressive Properties in Monocyte-Derived Dendritic Cells | Cancers | 270 days | save | | | |
| Cancers, Vol. 13, Pages 462: The Relevance of the SH2 Domain for c-Src Functionality in Triple-Negative Breast Cancer Cells | Cancers | 270 days | save | | | |
| Cancers, Vol. 13, Pages 459: Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers | Cancers | 270 days | save | | | |
| Cancers, Vol. 13, Pages 460: Experimental Models for Studying HPV-Positive and HPV-Negative Penile Cancer: New Tools for An Old Disease | Cancers | 270 days | save | | | |
| Cancers, Vol. 13, Pages 458: Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR | Cancers | 270 days | save | | | |
| Cancers, Vol. 13, Pages 457: Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery? | Cancers | 270 days | save | | | |
| | 
report | next » |
| |
